Top Markets
Coin of the day
AroCell AB (publ) AroCell AB (publ)

AroCell AB (publ)

AROC
Rank in Stocks #31790
AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on... AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on the surveillance of various cancerous conditions, such as hematological malignancies, breast cancer, and other solid tumors. The company develops, produces, and markets its flagship product, AroCell TK 210 ELISA, an immunoassay kit designed for measuring Thymidine Kinase 1 levels in human blood. Additionally, AroCell provides TUBEX TF, a rapid bacteriological test for the detection of typhoid fever. Founded in 2000, the firm was originally known as Xi Bao Research AB, adopting its current name, AroCell AB (publ), in 2006. It maintains its headquarters in Uppsala, Sweden.
Share Price
$0.05234265
Last synced: 2025-06-23
Market Cap
$12.06M
Change (1 day)
-3.01%
Change (1 year)
0.00%
Country
SE
Trade AroCell AB (publ) (AROC)

Category

Earnings for AroCell AB (publ) (AROC)
Earnings in 2026 TTM: 0
According to AroCell AB (publ) latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for AroCell AB (publ) from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US